Pyxis Oncology to Participate in Two Upcoming Investment Conferences
Provided By GlobeNewswire
Last update: Aug 31, 2023
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced its participation in two upcoming investment conferences.
